Karuna Therapeutics, Inc. KRTX
Set alert
At close · Mar 15
52-week range unavailable
- Open
- 329.75
- Prev close
- 329.83
- Mkt cap
- 12.60B
- Vol
- 1.28M
- Avg vol
- 0
- EPS
- 0.00
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 329.75
- High
- 329.97
- Forward P/E
- -36.49
- Beta
- 1.15
- Short ratio
- 3.60
- Inst. own
- 86.32%
- Dividend
- 0.00
- Ex-div date
- Earnings
- May 2, 2024
- 50-d avg
- 317.71
- 200-d avg
- 230.08
- 1y target
- 324.17
News
2 years ago zacks.com
Karuna's (KRTX) Q4 Loss Widens, Focus on Bristol Myers Buyout
Karuna's (KRTX) fourth-quarter 2023 earnings and revenues miss estimates. The company is set to be acquired by Bristol Myers.
2 years ago businesswire.com
Karuna Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides General Business Update
BOSTON--(BUSINESS WIRE)---- $KRTX--Karuna Therapeutics, Inc. (NASDAQ: KRTX), a biopharmaceutical company driven to discover, develop, and deliver transformative medicines for people living with…
2 years ago businesswire.com
KARUNA THERAPEUTICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Karuna Therapeutics, Inc. - KRTX
NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of Karuna…
2 years ago zacks.com
Bullish Continuation in '24? 3 Market Areas to Watch
Will stocks continue into 2024? Stock Strategist Andrew Rocco shares his prediction and unveils 3 important market areas to monitor.
-
2 years ago benzinga.com
5 Biotech Stocks That Should Be On Investors' Radar As JPMorgan Healthcare Conference Gets Underway Monday
The rebound by biopharma stocks in 2023 and the pickup in M&A news flow makes the 2024 JPMorgan Healthcare conference even more interesting.
2 years ago cnbc.com
Cramer names biopharma companies to watch as industry mergers start to pile up
CNBC's Jim Cramer pointed out the numerous mergers and acquisitions across the biopharma industry.
2 years ago businesswire.com
KARUNA THERAPEUTICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Karuna Therapeutics, Inc. - KRTX
NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of Karuna…
2 years ago zacks.com
Yes Virginia, There Is a Santa Claus Rally
The Russell is up an astounding +26% from late October, largely thanks to signaled interest rate cuts from the Fed in 2024.
2 years ago zacks.com
Karuna (KRTX) Up 48% on $14B Buyout Offer From Bristol Myers
Bristol Myers (BMY) is set to acquire Karuna (KRTX) for $330 per share. This transaction is expected to close in the first half of 2024.
2 years ago 247wallst.com
Nano Dimension Buys Stratasys, Bristol Myers's Shopping Spree, Apple Gets a ‘No'
The holiday shopping season isn't over yet. A 3-D printing company and a major pharmaceuticals maker announced post-Christmas acquisitions Tuesday morning.
2 years ago invezz.com
Bristol-Myers buying Karuna signals a biotech boom ahead: Jefferies
Karuna Therapeutics Inc (NASDAQ: KRTX) ended nearly 50% up on Friday after Bristol-Myers Squibb Co (NYSE: BMY) said it will buy the biopharmaceutical firm for $14 billion.
2 years ago prnewswire.com
ALERT: Rowley Law PLLC is Investigating Proposed Acquisition of Karuna Therapeutics, Inc.
NEW YORK , Dec. 22, 2023 /PRNewswire/ -- Rowley Law PLLC is investigating potential securities law violations by Karuna Therapeutics, Inc. (NASDAQ: KRTX) and its board of directors concerning the…
2 years ago proactiveinvestors.com
Bristol Myers Squibb buys neurological drug developer Karuna Therapeutics in $14B deal
Shares of biopharmaceutical company Karuna Therapeutics skyrocketed more than 47% Friday morning after giant Bristol-Myers Squibb Co (NYSE:BMY, ETR:RM, OTC:BMYMP) announced a deal to acquire the…
2 years ago investopedia.com
Midday Movers: Karuna Jumps on Deal With Bristol Myers Squibb, Nike Falls on Sales Outlook
U.S. equities headed into the long holiday weekend with gains at midday, amid a broad-based rally fueled by enthusiasm over the possibility of several Fed interest rate cuts next year. The Dow, S&P…
2 years ago investopedia.com
Bristol Myers Squibb Boosts Its Neuroscience Reach With $14 Billion Karuna Deal
Karuna Therapeutics (KRTX) shares skyrocketed over 46% after Bristol Myers Squibb (BMY) said it would buy the biopharmaceutical firm for $14 billion to expand its neuroscience portfolio.
2 years ago marketwatch.com
Biotech stocks set for a rebound in 2024, analysts say
A more favorable interest-rate outlook, an uptick in deals, and innovations in key areas like cancer and immunology are setting up biotech for a brighter 2024, analysts say.
2 years ago prnewswire.com
Shareholder Alert: Ademi LLP investigates whether Karuna Therapeutics, Inc. has obtained a Fair Price in its transaction with Bristol-Myers
MILWAUKEE , Dec. 22, 2023 /PRNewswire/ -- Ademi LLP is investigating Karuna (NASDAQ: KRTX) for possible breaches of fiduciary duty and other violations of law in its transaction with Bristol-Myers.…
2 years ago cnbc.com
Karuna Therapeutics surges 47% after Bristol Myers Squibb announces $14 billion deal
Bristol Myers Squibb said it agreed to buy biopharmaceutical company Karuna Therapeutics for $14 billion in cash.
2 years ago 24/7 Wall Street
A Major Acquisition and Other News Ahead of the Holiday Weekend
Before U.S. markets opened on Friday, the Bureau of Economic Analysis released its personal income and spending report for November.
2 years ago investors.com
Karuna Stock Soars On Bristol Myers' $14 Billion Takeover
Bristol Myers Squibb announced its $14 billion acquisition of Karuna Therapeutics on Friday, sending KRTX stock into the stratosphere.
2 years ago foxbusiness.com
Bristol Myers to buy Karuna Therapeutics for $14B
Karuna's crown jewel, an experimental drug called KarXT, is the product of such new insights. The drug could surpass $6 billion in yearly sales if it is approved for the various uses.
-
2 years ago benzinga.com
Earnings Scheduled For November 2, 2023
Companies Reporting Before The Bell • AudioCodes (NASDAQ:AUDC) is estimated to report quarterly earnings at $0.18 per share on revenue of $61.52 million.
-
3 years ago benzinga.com
Stocks That Hit 52-Week Lows On Tuesday
On Tuesday, 647 companies set new 52-week lows.
-
3 years ago benzinga.com
Earnings Scheduled For August 3, 2023
Companies Reporting Before The Bell • Cedar Fair (NYSE:FUN) is likely to report quarterly earnings at $1.10 per share on revenue of $512.74 million.
-
3 years ago benzinga.com
Earnings Scheduled For May 4, 2023
Companies Reporting Before The Bell • Cedar Fair (NYSE:FUN) is estimated to report quarterly loss at $1.83 per share on revenue of $104.21 million.
-
3 years ago benzinga.com
Benzinga's Top Ratings Upgrades, Downgrades For January 5, 2023
Benzinga's Top Ratings Upgrades, Downgrades For January 5, 2023
-
4 years ago benzinga.com
Why Karuna Therapeutics Jumped Around 72%; Here Are 96 Biggest Movers From Yesterday
Gainers Helbiz, Inc. (NASDAQ: HLBZ) jumped 114.6% to close at $1.61 on Monday after climbing over 27% on Friday.
-
4 years ago benzinga.com
Nasdaq Turns Lower; Crude Oil Rises Over 1%
U.S. stocks pared gains toward the end of trading, with the S&P 500 and the Nasdaq turning lower on Monday.
-
4 years ago benzinga.com
Why CinCor Pharma Is Trading Higher By 63%, Here Are 79 Stocks Moving In Monday's Mid-Day Session
Gainers Bonso Electronics International Inc. (NASDAQ: BNSO) shares jumped 132% to $11.12 after jumping around 46% on Friday. The company recently said it expects unaudited comprehensive loss of $1.6…
-
5 years ago benzinga.com
Stocks That Hit 52-Week Highs On Tuesday
On Tuesday, 596 companies set new 52-week highs.
-
7 years ago benzinga.com
Stocks That Hit 52-Week Lows On Tuesday
Stocks That Hit 52-Week Lows On Tuesday
-
7 years ago benzinga.com
Stocks That Fell Through 52-Week Lows Wednesday
Stocks That Fell Through 52-Week Lows Wednesday
-
7 years ago benzinga.com
Benzinga's Top Upgrades, Downgrades For July 23, 2019
Benzinga's Top Upgrades, Downgrades For July 23, 2019